Patients requiring dialysis are extremely vulnerable to infectious diseases. The high burden of comorbidities and weakened immune system due to uremia and previous immunosuppressive therapy expose the patient on dialysis to more infectious events than the general population. The infectious risk is further increased by the presence of endovascular catheters and implantable cardiologic devices.
View Article and Find Full Text PDFCOVID-19 is an unpredictable infectious disease caused by SARS-CoV-2. The development of effective anti-COVID-19 vaccines has enormously minimized the risk of severe illness in most immunocompetent patients. However, unvaccinated patients and non-responders to the COVID-19 vaccine are at risk of shortand long-term consequences.
View Article and Find Full Text PDFis a Gram-positive bacterium commonly associated with severe infections in hospitalized patients. produces many virulence factors leading to local and distant pathological processes. Invasiveness of generally induces metastatic infections such as bacteremia, infective endocarditis, osteomyelitis, arthritis, and endophthalmitis.
View Article and Find Full Text PDF[This corrects the article DOI: 10.1093/ckj/sfaa084.][This corrects the article DOI: 10.
View Article and Find Full Text PDFBackground: Dialysis patients are considered at high risk for COVID-19 and the infection can easily spread in dialysis units.
Methods: We conducted an observational single-centre cohort study to describe clinical characteristics, treatments and outcomes of dialysis patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We tested patients who presented symptoms or had contact with a confirmed case.